[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548185":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":12,"responsibleParty":60,"collaborators":62,"id":67,"slug":7,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":7,"enrollmentInfo":75,"targetDuration":7,"studyType":78,"phases":7,"briefSummary":79,"conditions":80,"keywords":7,"overallStatus":15,"whyStopped":7,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Zurich","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Neurological Assessment","Clinical neurological assessment performed by 2 raters",[13,32,46],{"facility":14,"status":15,"city":16,"state":17,"zip":18,"country":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"MD Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States",{"type":21,"coordinates":22},"Point",[23,24],-95.36327,29.76328,{"lat":24,"lon":23},[27],{"name":28,"role":29,"phone":30,"phoneExt":7,"email":31},"Barbara O'Brien","CONTACT","832-837-9347","BJOBrien@mdanderson.org",{"facility":33,"status":15,"city":34,"state":7,"zip":7,"country":35,"cosmosGeoPoint":36,"geoPoint":40,"contacts":41},"Netherlands Cancer Institute","Amsterdam","Netherlands",{"type":21,"coordinates":37},[38,39],4.88969,52.37403,{"lat":39,"lon":38},[42],{"name":43,"role":29,"phone":44,"phoneExt":7,"email":45},"Dieta Bransdma","+31 (0)20 512 9111","d.brandsma@nki.nl",{"facility":47,"status":15,"city":48,"state":7,"zip":7,"country":49,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"University Hospital Zurich","Zurich","Switzerland",{"type":21,"coordinates":51},[52,53],8.55,47.36667,{"lat":53,"lon":52},[56],{"name":57,"role":29,"phone":58,"phoneExt":7,"email":59},"Emilie Le Rhun","+41 44 255 38 99","emilie.lerhun@usz.ch",{"type":61,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[63,65],{"name":64,"class":6},"M.D. Anderson Cancer Center",{"name":66,"class":6},"The Netherlands Cancer Institute","100548185",false,"NCT06417710","Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis","NANO-LM","Inclusion Criteria:\n\n* Adult patients (18 years or more), female or male\n* Histologically confirmed diagnosis of extra-CNS primary solid cancer\n* Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria\n* Performance status compatible with enrolment into clinical trials\n* Ability to consent\n* Signed informed consent form from patient\n* Participation in a parallel clinical trial is allowed in this non-interventional study\n\nExclusion Criteria:\n\n* Inability to give informed consent\n* Inability to adhere to recommended follow-up according to the treating physician\n\nVulnerable participants will not be included.","ALL","18 Years",{"count":76,"type":77},200,"ESTIMATED","OBSERVATIONAL","The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.",[81,82,83,84],"Leptomeningeal Metastasis","Leptomeningeal Disease","Leptomeningeal Neoplasms","Leptomeningeal Cancer","2024-05-12",{"date":87,"type":88},"2024-05-16","ACTUAL",{"date":90,"type":88},"2022-01-30",{"date":92,"type":77},"2026-12",{"name":5,"class":6},3]